CS logo
small CS logo
Alexian Brothers Neurosciences Institute

Elk Grove Village, Illinois, United States
General hospital in Elk Grove Village, Illinois
800 Biesterfield Rd, Elk Grove Village, IL 60007

About Alexian Brothers Neurosciences Institute


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Genentech, Inc.
6
Biogen
4
Hoffmann-La Roche
4
Novartis
4
TauRx Therapeutics Ltd
4
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
3
Orasi Medical, Inc.
3
Pfizer
3
Eli Lilly and Company
2
Neurotrope Bioscience, Inc.
2
Bristol-Myers Squibb
1
Total Rows: 16

Clinical Trials at Alexian Brothers Neurosciences Institute


During the past decade, Alexian Brothers Neurosciences Institute conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 16 clinical trials were completed, i.e. on average, 106.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 11 clinical trials were completed. i.e. 275% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33111144222211110022112200551144Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
2006-06-01
2011-08-01
Completed
1,083
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
2007-12-01
2012-06-01
Completed
1,331
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
2007-12-01
2012-04-01
Completed
1,121
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
2008-06-01
2013-08-01
Terminated
901
Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
2008-12-05
2011-08-16
Completed
198
Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients
2008-10-01
Completed
31
A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
2009-07-01
2012-09-01
Terminated
896
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
2009-07-01
2012-06-01
Completed
716

Rows per page:

1–41 of 41

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Alexian Brothers Neurosciences Institute" #1 sponsor was "Genentech, Inc." with 6 trials, followed by "Biogen" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Novartis" with 4 trials sponsored and "TauRx Therapeutics Ltd" with 4 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Alexian Brothers Neurosciences Institute" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGenentech, Inc.: 6Genentech, Inc.: 6Biogen: 4Biogen: 4Hoffmann-La Roche: 4Hoffmann-La Roche: 4Novartis: 4Novartis: 4TauRx Therapeutics Ltd: 4TauRx Therapeutics Ltd: 4JANSSEN AlzheimerImmunotherapyResearch &Development, LLC: 3JANSSEN AlzheimerImmunotherapyResearch &Development, LLC: 3Orasi Medical, Inc.: 3Orasi Medical, Inc.: 3Pfizer: 3Pfizer: 3Eli Lilly and Company: 2Eli Lilly and Company: 2Neurotrope Bioscience, Inc.: 2Neurotrope Bioscience, Inc.: 2

Created with Highcharts 11.1.0Top CollaboratorsPfizer: 3Pfizer: 3Medpace, Inc.: 1Medpace, Inc.: 1Worldwide Clinical Trials: 1Worldwide Clinical Trials: 1

Clinical Trials Conditions at Alexian Brothers Neurosciences Institute


According to Clinical.Site data, the most researched conditions in "Alexian Brothers Neurosciences Institute" are "Alzheimer's Disease" (24 trials), "Alzheimer Disease" (8 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (1 trials), "Alzheimer Disease (AD)" (1 trials) and "Alzheimer Disease, Early Onset" (1 trials). Many other conditions were trialed in "Alexian Brothers Neurosciences Institute" in a lesser frequency.

Clinical Trials Intervention Types at Alexian Brothers Neurosciences Institute


Most popular intervention types in "Alexian Brothers Neurosciences Institute" are "Drug" (38 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "placebo" (4 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "Crenezumab" (3 trials) and "Aducanumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Alexian Brothers Neurosciences Institute


The vast majority of trials in "Alexian Brothers Neurosciences Institute" are 39 trials for "All" genders and 2 trials for "Male" genders.

Clinical Trials Status at Alexian Brothers Neurosciences Institute


Currently, there are NaN active trials in "Alexian Brothers Neurosciences Institute". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Alexian Brothers Neurosciences Institute, undefined suspended trials, and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Alexian Brothers Neurosciences Institute, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 20Phase 3: 20Phase 2: 16Phase 2: 16Not Applicable: 2Not Applicable: 2Phase 1: 2Phase 1: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 22Completed: 22Terminated: 10Terminated: 10Active, not recruiting: 3Active, not recruiting: 3Recruiting: 3Recruiting: 3Unknown status: 3Unknown status: 3